Referencias: 1. Skolnik NS, Carnahan SP. Primary care of asthma: new options for severe eosinophilic asthma. Curr Med Res Opin. 2019;35(7):1309-1318.
doi:10.1080/03007995.2019.1595966
2. Hussain M, Liu G. Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons. Cells. 2024;13(5):384. Published 2024 Feb 23.
doi:10.3390/cells13050384
3. D'Aiuto V, Mormile I, Granata F, et al. Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target
Treatment. Int J Mol Sci. 2025;26(4):1729. Published 2025 Feb 18. doi:10.3390/ijms26041729
4. Guía Española para el Manejo del Asma (GEMA) 5.5. 2025. www.gemasma.com
5. Reddel H, Bateman E, FitzGerald G, et al. 2025 Global Strategy for Asthma Management and Prevention. GINA. 2025. https://
ginasthma.org/2025-gina-strategy-report/